Best-of-Breed Versus Enterprise LIS Under a Capital Deadline
A 250-bed hospital and its 40-provider pathology group are selecting a new laboratory information system. The current system is 18 years old and cannot support digital pathology or structured synoptic reporting. Hospital IT favors the enterprise EHR vendor's laboratory module; the pathologists prefer a best-of-breed anatomic pathology system with a published interface. In scripted demos, the enterprise module scores 62 of 100 on AP workflow, while best-of-breed scores 88 but requires a $1.1 million interface and a separate downtime procedure. The CFO has approved $3.5 million. A decision is needed in six weeks to secure capital. Two pathologists will retire within 18 months. The interface engine team is already at 110% capacity.
1. Recommend a decision framework and how you would weigh the competing options.
Read the worked answer
Recommendation: use a weighted decision framework, and do not let the six-week capital deadline force an irreversible choice.
Criteria and weights (example)
- AP clinical workflow fit (synoptic reporting, grossing, digital pathology, staining): 30%
- Interface feasibility and downtime safety: 20%
- Total cost of ownership, including the $1.1 million interface and ongoing support: 15%
- Integration with the enterprise EHR for orders and results: 15%
- Vendor viability, roadmap, and references: 10%
- Implementation risk and pathologist adoption: 10%
Analysis
- The enterprise module's 62/100 AP score is a warning: pathologists may resist, work around, or leave. The best-of-breed option offers better workflow but adds interface cost and depends on a team already at 110% capacity.
- A hybrid (enterprise for clinical pathology, best-of-breed for AP) can be reasonable if the interface is robust and downtime is planned.
- Request scripted demos using your own cases, site visits, and reference calls with similar-sized pathology groups.
Process
- Include pathologists, laboratory leadership, IT, finance, and the CMIO in scoring.
- Ask the board or CFO for a short extension or a conditional approval pending interface assessment. A six-week deadline is a business constraint, not a clinical requirement.
2. What implementation and risk-mitigation steps would you require for either option?
Read the worked answer
If best-of-breed is selected
- Contract for interface deliverables, milestones, acceptance testing, and penalties for delay.
- Fund additional interface-engine capacity or a contractor; do not assume the current team can absorb the work at 110% utilization.
- Define downtime procedures and validate them before go-live.
- Phase implementation: AP first, then interfaces, then digital pathology.
- Protect against knowledge loss from the two retiring pathologists: capture workflows now and designate younger champions.
If the enterprise module is selected
- Negotiate a written AP roadmap with acceptance criteria and exit clauses.
- Pilot synoptic reporting and grossing with a small group before enterprise-wide rollout.
- Budget for optimization and possibly a future best-of-breed AP layer.
Common mitigations
- Data migration and validation plan.
- Training and superusers; at-the-elbow support.
- Benefits realization and post-implementation review at 6 and 12 months.
- Risk register with owners and triggers.
3. How would you structure governance and change management to reach a defensible decision?
Read the worked answer
Governance
- Establish a steering committee with decision rights: CMIO or CMO as chair, laboratory medical director, CFO, CIO, pathology representatives, and a project manager.
- Use a transparent scoring rubric and document dissent.
- Separate vendor demonstrations from scripted clinical scenarios; do not let the vendor control the demo.
- Require conflict-of-interest disclosures.
Change management
- Engage pathologists early; use their workflow data in the decision.
- Communicate the rationale for the final choice, including trade-offs.
- Identify champions and resistors; address concerns with evidence.
- Plan for training, workflow redesign, and a productivity dip during go-live.
Accountability
- Define success metrics: report turnaround, synoptic reporting completeness, pathologist satisfaction, interface uptime, and cost per report.
- Report to the board at milestones.
- Build in a post-decision review so the organization learns from the process.